- Divesting infant formula business for up to $175M ($40M upfront cash, $135M contingent milestones).
- Unit generated $380M net sales and $8M adjusted operating income in TTM.
- Perrigo expects a Q4 2026 pre-tax impairment charge of $275M to $375M.
?? Negative AI Sentiment (-2.0 / 10)